SPRUCE BIOSCIENCES, INC. short interest in 2023
In 2023, SPRUCE BIOSCIENCES, INC.'s disclosed short interest ran from 5.13% of shares outstanding on 13 Jan 2023 to 0.19% on 29 Dec 2023, a change of -4.94 percentage points. The year's high was 5.13% on 13 Jan 2023 and its low 0.06% on 13 Oct 2023, averaging 1.81% across 19 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 16.70 days on 15 May 2023. Full history: SPRUCE BIOSCIENCES, INC..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 5.13% (13 Jan 2023)
- End of year
- 0.19% (29 Dec 2023)
- Change
- -4.94 pp
- High
- 5.13% (13 Jan 2023)
- Low
- 0.06% (13 Oct 2023)
- Average
- 1.81%
- Highest days to cover
- 16.70 (15 May 2023)
- SEC filings marked
- 9
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 5.13% | 1.00 | results (8-K) |
| 31 Jan 2023 | 3.50% | 3.56 | |
| 15 Feb 2023 | 3.56% | 2.69 | |
| 28 Feb 2023 | 4.63% | 2.73 | |
| 15 Mar 2023 | 2.64% | 6.68 | |
| 31 Mar 2023 | 3.06% | 9.06 | 10-K filed, results (8-K) |
| 14 Apr 2023 | 3.54% | 10.50 | |
| 28 Apr 2023 | 3.33% | 11.69 | |
| 15 May 2023 | 2.89% | 16.70 | 10-Q filed, results (8-K) |
| 31 May 2023 | 1.18% | 1.78 | |
| 15 Aug 2023 | 0.08% | 1.00 | 10-Q filed, results (8-K) |
| 31 Aug 2023 | 0.07% | 1.00 | |
| 29 Sep 2023 | 0.09% | 1.45 | |
| 13 Oct 2023 | 0.06% | 1.00 | |
| 31 Oct 2023 | 0.09% | 1.00 | |
| 15 Nov 2023 | 0.17% | 1.00 | 10-Q filed, results (8-K) |
| 30 Nov 2023 | 0.13% | 1.00 | |
| 15 Dec 2023 | 0.11% | 1.00 | |
| 29 Dec 2023 | 0.19% | 1.00 |
See also: SPRUCE BIOSCIENCES, INC.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.